medigraphic.com

2018, Number 1

<< Back Next >>

Rev Fac Med UNAM 2018; 61 (1)

Obstructive sleep apnea hypopnea syndrome and benzodiazepine consumption in older adults

Barrera MA

Language: Spanish
References: 18
Page: 21-25
PDF size: 538.78 Kb.


ABSTRACT

Introduction: Obstructive sleep apnea hypopnea syndrome (OSAHS) is caused by an obstruction in the upper airway during sleep. Obesity and advanced age are main risk factors for OSAHS. The classic symptoms of OSAHS include snoring, apneas and choking during sleep. On the other hand, some scientific literature describes that the consumption of benzodiazepines may worsen the snoring and the severity and duration of OSAHS. Case report: A 74-year-old female reported on her appointment to have mood alterations. When asked about other sleep disorders, she said that she snored loudly, with pauses on her breathing. Therefore, a split night polysomnography was performed which revealed a diagnosis of severe OSAHS. Discussion: Old people are frequent consumers of benzodiazepines. The woman of this study had been taking 1.5 mg of clonazepam per day for the last eight years. This may have worsened the OSAHS. Conclusion: The patient presented risk factors that could lead to OSAHS. It is important to study the relationship between benzodiazepines and the severity of OSAHS.


REFERENCES

  1. Russell T, Duntley S. Sleep disordered breathing in the elderly. The American Journal of Medicine. 2011;124:1123-6.

  2. Lam J, Sharma SK, Lam B. Obstructive sleep apnoea definitions, epidemiology & natural history. Indian Journal of Medical Research. 2010;131:165-70.

  3. Miller J, Berger A. Screening and assessment for obstructive sleep apnea in primary care. Sleep Medicine Reviews. 2016;29:41-51.

  4. Epstein L, Kristo D, Strollo P, Friedman N, Malhotra A, Patil S, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. Journal of Clinical Sleep Medicine. 2009;5:263-76.

  5. Young T, Peppard PE, Gottlieb DJ. Epidemiology of ob- A. Barrera Medina structive sleep apnea: a population health perspective. American Journal of Respiratory and Critical Care Medicine. 2002;165:1217-39.

  6. Miner B, Kryger M. Sleep in the aging population. Sleep Medicine Clinics. 2017;12:31-8.

  7. Umlauf MG, Chasens ER, Greevy RA, Arnold J, Burgio KL, Pillion DJ. Obstructive sleep apnea, nocturia and polyuria in older adults. Sleep. 2004;27:139-44.

  8. Bloom HG, Ahmed I, Alessi CA, Ancoli-Israel S, Buysse DJ, Kryger MH, et al. Evidence based recommendations for the assessment and management of sleep disorders in older persons. Journal of the American Geriatrics Society. 2009;57:761-89.

  9. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. New England Journal of Medicine. 2000; 342:1378-84.

  10. Yaggi HK, Concato J, Kernan WN, Lichtman J, Brass L, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. New England Journal of Medicine. 2005; 353:2034-41.

  11. Ng Susanna, Chan T-O, To K-W, Chan K, Ngai J, Tung A, et al. Prevalence of sleep apnea syndrome and CPAP adherence in the elderly Chinese population. Plos One. 2015;10:1-15.

  12. Seda G, Tsai S, Lee-Chiong T. Medication effects on sleep breathing. Clinics in Chest Medicine. 2014;35:557-69.

  13. Soyka M. Treatment of benzodiazepine dependence. New England Journal of Medicine. 2017;376:1147-57.

  14. Spanemberg L, Lopes Nogueira E, Belem da Silva CT, Ayul Dargel A, Silva Menezes F, Cataldo Neto A, et al. High prevalence and prescription of benzodiazepines for elderly: data from psychiatric consultation to patients from an emergency room of a general hospital. General Hospital Psychiatry. 2011;33:45-50.

  15. Dolly Ray F, Block AJ. Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. The American Journal of Medicine. 1982;73:239-43.

  16. The Cochrane Database Systematic Reviews 2015, Issue 7 [CD011090]. John Wiley&Sons, Ltd. Mason M, Cates CJ, Smith I. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea. Doi: 10.1002/14651858.CD011090. pub2. PubMed PMID: 25774657; PubMed Central PMCID: 4361659.

  17. Schuld A, Kraus T, Haack M, Hinze-Selch D, Pollmacher T. Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep behavior disorder. Journal of Sleep Research. 1999;8:321-2.

  18. Karsten J. Low doses of mirtazapine or quetiapine for transient insomnia: A randomized, double-blind, cross-over, placebo-controlled trial. Journal of Psychopharmacology. 2017;3:327-37.




2020     |     www.medigraphic.com